Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Endocrine 1

Conditions

Multiple Myeloma 26Neoplasms, Plasma Cell 20Lymphoma 16Neuroblastoma 12Neoplasm Metastasis 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myeloid, Acute 7Sarcoma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Leukemia 6Colorectal Neoplasms 6Rectal Neoplasms 5Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Colonic Neoplasms 5Liver Neoplasms 4Immunoglobulin Light-chain Amyloidosis 4Hodgkin Disease 4Burkitt Lymphoma 4Recurrence 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms 3Melanoma 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hyperthermia 3Hematologic Neoplasms 3

Interventions

Trastuzumab 2tipifarnib 1temsirolimus 1romidepsin 1antineoplaston AS 2-1 1antineoplaston A10 1Streptozocin 1Sorafenib 1Sirolimus 1Oxaliplatin 1Melphalan 1Leucovorin 1Interleukin-12 Subunit p35 1Interleukin-12 1Gefitinib 1Floxuridine 1Complementary Therapies 1Cisplatin 1Capecitabine 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Carcinoma, Islet Cell × Melphalan × Clear all
NCT00019786 2012-03-23

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
67 enrolled
EndocrineGastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Liver Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Islet Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡